OA11350A - Dofetilide polymorphs. - Google Patents

Dofetilide polymorphs. Download PDF

Info

Publication number: OA11350A
Authority: OA; OAPI
Prior art keywords: dofetilide; polymorph; dofetilide polymorph; dofetiiide; shows
Prior art date: 1997-10-27

Application number

OA1200000117A

Other languages

English (en)

Inventor

Ian Colin Appleby

Gary Nichols

Trevor Jack Newbury

Original Assignee

Pfizer Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-27

Filing date

2000-04-20

Publication date

2003-12-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA11350(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-04-20 Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev

2003-12-17 Publication of OA11350A publication Critical patent/OA11350A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Cardiology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrrole Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

OA1200000117A 1997-10-27 2000-04-20 Dofetilide polymorphs. OA11350A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9722662.5A GB9722662D0 (en)	1997-10-27	1997-10-27	Polymorphs

Publications (1)

Publication Number	Publication Date
OA11350A true OA11350A (en)	2003-12-17

Family

ID=10821150

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA1200000117A OA11350A (en)	1997-10-27	2000-04-20	Dofetilide polymorphs.

Country Status (47)

Country	Link
US (1)	US6124363A (pt)
EP (1)	EP1027329B1 (pt)
JP (1)	JP3569495B2 (pt)
KR (1)	KR100366167B1 (pt)
CN (1)	CN1146537C (pt)
AP (1)	AP906A (pt)
AR (1)	AR015193A1 (pt)
AT (1)	ATE232199T1 (pt)
AU (1)	AU737668B2 (pt)
BG (1)	BG64125B1 (pt)
BR (1)	BR9813308A (pt)
CA (1)	CA2307121C (pt)
CO (1)	CO4970768A1 (pt)
DE (1)	DE69811256T2 (pt)
DK (1)	DK1027329T3 (pt)
DZ (1)	DZ2632A1 (pt)
EA (1)	EA002656B1 (pt)
ES (1)	ES2190620T3 (pt)
GB (1)	GB9722662D0 (pt)
GT (1)	GT199800165A (pt)
HK (1)	HK1033933A1 (pt)
HN (1)	HN1998000165A (pt)
HR (1)	HRP20000247B1 (pt)
HU (1)	HUP0004735A3 (pt)
ID (1)	ID24658A (pt)
IL (1)	IL135435A0 (pt)
IS (1)	IS2179B (pt)
MA (1)	MA24683A1 (pt)
MY (1)	MY123352A (pt)
NO (1)	NO325630B1 (pt)
NZ (1)	NZ503785A (pt)
OA (1)	OA11350A (pt)
PA (1)	PA8462001A1 (pt)
PE (1)	PE122199A1 (pt)
PL (1)	PL197379B1 (pt)
PT (1)	PT1027329E (pt)
SA (1)	SA98190834B1 (pt)
SI (1)	SI1027329T1 (pt)
SK (1)	SK5862000A3 (pt)
TN (1)	TNSN98193A1 (pt)
TR (1)	TR200001135T2 (pt)
TW (1)	TW449589B (pt)
UA (1)	UA67755C2 (pt)
UY (2)	UY25222A1 (pt)
WO (1)	WO1999021829A1 (pt)
YU (1)	YU24000A (pt)
ZA (1)	ZA989719B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10019067C1 (de) *	2000-04-18	2001-10-04	Lohmann Therapie Syst Lts	Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) *	2005-05-12	2008-02-05	Penta Biotech, Inc.	Peptide for assaying hERG channel binding
CZ307826B6 (cs)	2017-12-01	2019-05-29	Farmak, A.S.	Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11696902B2 (en)	2018-08-14	2023-07-11	AltaThera Pharmaceuticals, LLC	Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en)	2021-08-20	2023-03-21	AltaThera Pharmaceuticals LLC	Antiarrhythmic drug dosing methods, medical devices, and systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EG18188A (en) *	1986-05-01	1992-09-30	Pfizer Ltd	Process for preparation anti-arhythmia agents
EP0898964A1 (en) *	1997-08-19	1999-03-03	Pfizer Inc.	Method for treating heart failure

1997
- 1997-10-27 GB GBGB9722662.5A patent/GB9722662D0/en not_active Ceased
1998
- 1998-09-10 UA UA2000042087A patent/UA67755C2/uk unknown
- 1998-10-08 TW TW087116747A patent/TW449589B/zh not_active IP Right Cessation
- 1998-10-09 JP JP2000517941A patent/JP3569495B2/ja not_active Expired - Fee Related
- 1998-10-09 CA CA002307121A patent/CA2307121C/en not_active Expired - Fee Related
- 1998-10-09 PT PT98965638T patent/PT1027329E/pt unknown
- 1998-10-09 KR KR10-2000-7004471A patent/KR100366167B1/ko not_active IP Right Cessation
- 1998-10-09 DK DK98965638T patent/DK1027329T3/da active
- 1998-10-09 IL IL13543598A patent/IL135435A0/xx not_active IP Right Cessation
- 1998-10-09 YU YU24000A patent/YU24000A/sh unknown
- 1998-10-09 AT AT98965638T patent/ATE232199T1/de not_active IP Right Cessation
- 1998-10-09 BR BR9813308-0A patent/BR9813308A/pt not_active Application Discontinuation
- 1998-10-09 TR TR2000/01135T patent/TR200001135T2/xx unknown
- 1998-10-09 HU HU0004735A patent/HUP0004735A3/hu unknown
- 1998-10-09 US US09/423,986 patent/US6124363A/en not_active Expired - Lifetime
- 1998-10-09 EA EA200000365A patent/EA002656B1/ru not_active IP Right Cessation
- 1998-10-09 NZ NZ503785A patent/NZ503785A/en unknown
- 1998-10-09 PL PL340805A patent/PL197379B1/pl unknown
- 1998-10-09 DE DE69811256T patent/DE69811256T2/de not_active Expired - Fee Related
- 1998-10-09 SI SI9830347T patent/SI1027329T1/xx unknown
- 1998-10-09 WO PCT/EP1998/006641 patent/WO1999021829A1/en not_active Application Discontinuation
- 1998-10-09 EP EP98965638A patent/EP1027329B1/en not_active Expired - Lifetime
- 1998-10-09 AU AU21512/99A patent/AU737668B2/en not_active Ceased
- 1998-10-09 SK SK586-2000A patent/SK5862000A3/sk unknown
- 1998-10-09 ES ES98965638T patent/ES2190620T3/es not_active Expired - Lifetime
- 1998-10-09 ID IDW20000767A patent/ID24658A/id unknown
- 1998-10-09 CN CNB988106213A patent/CN1146537C/zh not_active Expired - Fee Related
- 1998-10-22 PA PA19988462001A patent/PA8462001A1/es unknown
- 1998-10-22 AP APAP/P/1998/001371A patent/AP906A/en active
- 1998-10-23 AR ARP980105310A patent/AR015193A1/es unknown
- 1998-10-23 MY MYPI98004829A patent/MY123352A/en unknown
- 1998-10-23 PE PE1998001003A patent/PE122199A1/es not_active Application Discontinuation
- 1998-10-26 TN TNTNSN98193A patent/TNSN98193A1/fr unknown
- 1998-10-26 UY UY25222A patent/UY25222A1/es not_active IP Right Cessation
- 1998-10-26 ZA ZA9809719A patent/ZA989719B/xx unknown
- 1998-10-26 HN HN1998000165A patent/HN1998000165A/es unknown
- 1998-10-26 DZ DZ980242A patent/DZ2632A1/xx active
- 1998-10-26 MA MA25313A patent/MA24683A1/fr unknown
- 1998-10-27 GT GT199800165A patent/GT199800165A/es unknown
- 1998-10-27 CO CO98062885A patent/CO4970768A1/es unknown
- 1998-11-28 SA SA98190834A patent/SA98190834B1/ar unknown
1999
- 1999-01-08 UY UY25341A patent/UY25341A1/es not_active IP Right Cessation
2000
- 2000-03-31 IS IS5426A patent/IS2179B/is unknown
- 2000-04-20 OA OA1200000117A patent/OA11350A/en unknown
- 2000-04-24 BG BG104373A patent/BG64125B1/bg unknown
- 2000-04-27 NO NO20002191A patent/NO325630B1/no not_active IP Right Cessation
- 2000-04-27 HR HR970680A patent/HRP20000247B1/xx not_active IP Right Cessation
2001
- 2001-06-21 HK HK01104340A patent/HK1033933A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
BG64125B1 (bg)	2004-01-30
PL340805A1 (en)	2001-02-26
KR100366167B1 (ko)	2003-01-09
ATE232199T1 (de)	2003-02-15
IS5426A (is)	2000-03-31
AP906A (en)	2000-11-30
CA2307121A1 (en)	1999-05-06
DE69811256T2 (de)	2003-09-18
HN1998000165A (es)	1999-02-09
EP1027329A1 (en)	2000-08-16
CA2307121C (en)	2006-12-05
ID24658A (id)	2000-07-27
YU24000A (sh)	2003-02-28
CN1146537C (zh)	2004-04-21
NO20002191L (no)	2000-04-27
US6124363A (en)	2000-09-26
HK1033933A1 (en)	2001-10-05
GT199800165A (es)	2000-04-19
KR20010031439A (ko)	2001-04-16
HUP0004735A3 (en)	2001-12-28
AU737668B2 (en)	2001-08-30
PA8462001A1 (es)	2000-05-24
IS2179B (is)	2006-12-15
DK1027329T3 (da)	2003-02-24
NO325630B1 (no)	2008-06-30
TNSN98193A1 (fr)	2005-03-15
TW449589B (en)	2001-08-11
TR200001135T2 (tr)	2000-09-21
NO20002191D0 (no)	2000-04-27
JP2001521023A (ja)	2001-11-06
GB9722662D0 (en)	1997-12-24
BG104373A (en)	2000-12-29
EA002656B1 (ru)	2002-08-29
JP3569495B2 (ja)	2004-09-22
PT1027329E (pt)	2003-04-30
UY25222A1 (es)	2000-12-29
CN1278246A (zh)	2000-12-27
SK5862000A3 (en)	2001-10-08
HUP0004735A2 (hu)	2001-10-28
SA98190834B1 (ar)	2006-08-21
BR9813308A (pt)	2000-08-22
MA24683A1 (fr)	1999-07-01
CO4970768A1 (es)	2000-11-07
HRP20000247A2 (en)	2000-10-31
IL135435A0 (en)	2001-05-20
AR015193A1 (es)	2001-04-18
UA67755C2 (uk)	2004-07-15
PE122199A1 (es)	1999-12-02
NZ503785A (en)	2004-11-26
MY123352A (en)	2006-05-31
SI1027329T1 (en)	2003-04-30
UY25341A1 (es)	1999-09-27
DZ2632A1 (fr)	2003-03-08
HRP20000247B1 (en)	2002-08-31
DE69811256D1 (de)	2003-03-13
WO1999021829A1 (en)	1999-05-06
EA200000365A1 (ru)	2000-12-25
EP1027329B1 (en)	2003-02-05
AP9801371A0 (en)	1998-12-31
AU2151299A (en)	1999-05-17
PL197379B1 (pl)	2008-03-31
ES2190620T3 (es)	2003-08-01
ZA989719B (en)	2000-04-26

Publication	Publication Date	Title
DE69425736T2 (de)	2001-04-12	Formyl- oder Cyano- substituierte Indolderivate mit dopaminergischer Wirkung
HU229563B1 (en)	2014-02-28	Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation and pharmaceutical compositions containing the crystalline forms
JPS6344572A (ja)	1988-02-25	抗不整脈剤
EP0161599A2 (de)	1985-11-21	Neue Benzazepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
OA11350A (en)	2003-12-17	Dofetilide polymorphs.
JPS6126996B2 (pt)	1986-06-23
EP0074014A1 (de)	1983-03-16	2-(2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, seine Säureadditionssalze, Verfahren zu seiner Herstellung und Arzneimittel
PT87219B (pt)	1992-12-31	Processo para a preparacao de sulfonildeca-hidro-8h-isoquino{2,1-g} {1,6}naftiridinas, de seus isomeros opticos e de compostos afins
JPH04178356A (ja)	1992-06-25	光学活性なベンジルアルコール誘導体及びその用途
DE69022442T2 (de)	1996-05-09	Aminoalkoxyphenyl-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen.
JPH0633247B2 (ja)	1994-05-02	３―アミノプロポキシフェニル誘導体およびその製法ならび用途
MXPA00004059A (en)	2002-03-26	Dofetilide polymorphs
CN116120327B (zh)	2025-03-21	β-榄香烯13,14-位对称的双取代衍生物及其制备方法和应用
CZ20001516A3 (cs)	2001-07-11	Polymorfy dofetilidu
US6774263B1 (en)	2004-08-10	Pharmaceutically active compound and methods of use
IL47060A (en)	1977-12-30	Quaternary ammonium salts of n-dialkylaminoalkyl-n-(2-indanyl)anilines
EP3939578A1 (en)	2022-01-19	Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease
JPS6112624A (ja)	1986-01-21	抗高血圧剤
CA2306276A1 (en)	1999-04-22	Pharmaceutically active compound and methods of use
CN113087686A (zh)	2021-07-09	一类含氰基的双季铵类化合物及其制备方法和用途
WO1999009001A1 (fr)	1999-02-25	Derives de phenylethanolaminotetraline et bronchodilatateurs
JPS63122663A (ja)	1988-05-26	シクロペンチルエーテル，その製法およびその医薬組成物
JPH01153663A (ja)	1989-06-15	血圧降下剤
JPH0527616B2 (pt)	1993-04-21
LU82394A1 (fr)	1980-07-31	Nouvelles quinazolines,leur procede de production et medicament les contenant